FIELD: chemistry.
SUBSTANCE: invention relates to a method for producing amorphous co-evaporate containing (a) cladribine, (b) cyclodextrin and (c) an organic solvent, said method comprising the steps of: (i) dissolving cyclodextrin in an aqueous alcoholic solution, (ii) dissolving cladribine in aqueous alcoholic solution of cyclodextrin, (iii) removing the solvent to obtain the final amorphous co-volatilized substance containing less than 2% residual solvent.
EFFECT: new method for preparing an amorphous complex of cladribine with cyclodextrin has been developed, which makes it possible to obtain a highly stable amorphous complex that can be used in medicine for the production of solid dosage forms containing cladribine.
8 cl, 7 dwg, 10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION CONTAINING SOLID DISPERSIONS OF AMORPHOUS CLADRIBINE AND PHARMACEUTICALLY ACCEPTABLE WATER-SOLUBLE CARRIER | 2020 |
|
RU2748311C1 |
| SALTS OF DASATINIB IN AMORPHOUS FORM | 2014 |
|
RU2655435C2 |
| SOLID FORMS OF (1,1-DIOXO-4-THIOMORPHOLINYL) - [6 - [[3- (4-FLUOROPHENYL) -5-METHYL-4-ISOXAZOLYL] METHOXY] -3-PYRIDINYL] METHANONE | 2012 |
|
RU2618524C2 |
| DASATINIB SALTS IN CRYSTALLINE FORM | 2014 |
|
RU2662805C2 |
| COMPOUND ON BASIS OF ARIPIPRAZOLE COMPLEX | 2003 |
|
RU2342931C2 |
| PHARMACEUTICAL COMPOSITION AND METHODS FOR USE | 2017 |
|
RU2719450C1 |
| AEROSOLIZED FLUOROQUINOLONES AND USES THEREOF | 2006 |
|
RU2603638C2 |
| METHOD FOR OBTAINING SUSPENSION CONTAINING NANOSIZED PARTICLES OF DRUG | 2020 |
|
RU2756757C1 |
| PERINDOPRIL INCLUSION COMPLEXES | 2005 |
|
RU2372353C2 |
| INCLUSION COMPLEX OF DISULFIRAM AND CYCLODEXTRIN | 2015 |
|
RU2592625C1 |
